{"entity":{"type":"insider","cik":"0001635616","url":"/insider/0001635616","json_url":"/insider/0001635616.json","name":"Brockstedt Dirk G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":41,"first":"2015-11-18","last":"2024-01-08","span_basis":"filed_date"},"name_variants":[{"name":"Brockstedt Dirk G.","source":"filing","n_filings":41,"first_seen":"2015-11-18","last_seen":"2024-01-08"}],"transactions":[{"id":2594983,"accession":"0001415889-24-000817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-000817","line_url":"/filing/0001415889-24-000817#line-1","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (CHIEF SCIENTIFIC OFFICER)","officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":898.0,"shares_display":"898","price_per_share":22.78,"price_display":"22.78","price_state":"stated","total_value":20456.44,"total_display":"20,456.44","shares_owned_after":27820.0,"shares_owned_after_display":"27,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-08","scope":"insider"},{"id":8088011,"accession":"0001593968-23-000096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-23-000096","line_url":"/filing/0001593968-23-000096#line-1","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":742.0,"shares_display":"742","price_per_share":21.966,"price_display":"21.97","price_state":"stated","total_value":16298.772,"total_display":"16,298.77","shares_owned_after":19070.0,"shares_owned_after_display":"19,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":6356697,"accession":"0001593968-22-000920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-22-000920","line_url":"/filing/0001593968-22-000920#line-1","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":720.0,"shares_display":"720","price_per_share":15.05,"price_display":"15.05","price_state":"stated","total_value":10836.0,"total_display":"10,836.00","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-05","scope":"insider"},{"id":6660432,"accession":"0001593968-22-000858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-22-000858","line_url":"/filing/0001593968-22-000858#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":23.05,"price_display":"23.05","price_state":"stated","total_value":61013.35,"total_display":"61,013.35","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-12","scope":"insider"},{"id":6377105,"accession":"0001593968-22-000745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-22-000745","line_url":"/filing/0001593968-22-000745#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2648.0,"shares_display":"2,648","price_per_share":23.91,"price_display":"23.91","price_state":"stated","total_value":63313.68,"total_display":"63,313.68","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":6256224,"accession":"0001593968-22-000454","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-22-000454","line_url":"/filing/0001593968-22-000454#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":22.47,"price_display":"22.47","price_state":"stated","total_value":59478.09,"total_display":"59,478.09","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":6762359,"accession":"0001593968-22-000210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-22-000210","line_url":"/filing/0001593968-22-000210#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2648.0,"shares_display":"2,648","price_per_share":32.16,"price_display":"32.16","price_state":"stated","total_value":85159.68,"total_display":"85,159.68","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider"},{"id":5338189,"accession":"0001593968-21-002537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002537","line_url":"/filing/0001593968-21-002537#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":30.88,"price_display":"30.88","price_state":"stated","total_value":81739.36,"total_display":"81,739.36","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-13","scope":"insider"},{"id":5122944,"accession":"0001593968-21-002535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002535","line_url":"/filing/0001593968-21-002535#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2648.0,"shares_display":"2,648","price_per_share":35.69,"price_display":"35.69","price_state":"stated","total_value":94507.12,"total_display":"94,507.12","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-12-10","scope":"insider"},{"id":5418617,"accession":"0001593968-21-002256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002256","line_url":"/filing/0001593968-21-002256#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":30.78,"price_display":"30.78","price_state":"stated","total_value":81474.66,"total_display":"81,474.66","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-12","scope":"insider"},{"id":4908289,"accession":"0001593968-21-002115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002115","line_url":"/filing/0001593968-21-002115#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2648.0,"shares_display":"2,648","price_per_share":35.78,"price_display":"35.78","price_state":"stated","total_value":94745.44,"total_display":"94,745.44","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-13","scope":"insider"},{"id":4391534,"accession":"0001593968-21-001967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001967","line_url":"/filing/0001593968-21-001967#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":31.19,"price_display":"31.19","price_state":"stated","total_value":82559.93,"total_display":"82,559.93","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-12","scope":"insider"},{"id":5229125,"accession":"0001593968-21-001833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001833","line_url":"/filing/0001593968-21-001833#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2648.0,"shares_display":"2,648","price_per_share":33.53,"price_display":"33.53","price_state":"stated","total_value":88787.44,"total_display":"88,787.44","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-13","scope":"insider"},{"id":4278068,"accession":"0001593968-21-001630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001630","line_url":"/filing/0001593968-21-001630#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":18.55,"price_display":"18.55","price_state":"stated","total_value":49101.85,"total_display":"49,101.85","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-15","scope":"insider"},{"id":4798534,"accession":"0001593968-21-001321","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001321","line_url":"/filing/0001593968-21-001321#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2648.0,"shares_display":"2,648","price_per_share":18.19,"price_display":"18.19","price_state":"stated","total_value":48167.12,"total_display":"48,167.12","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":5381962,"accession":"0001593968-21-001243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-21-001243","line_url":"/filing/0001593968-21-001243#line-1","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2084.0,"shares_display":"2,084","price_per_share":21.56,"price_display":"21.56","price_state":"stated","total_value":44931.04,"total_display":"44,931.04","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-06","scope":"insider"},{"id":4332812,"accession":"0001593968-21-000530","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001593968-21-000530","line_url":"/filing/0001593968-21-000530#line-3","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9877.0,"shares_display":"9,877","price_per_share":21.22,"price_display":"21.22","price_state":"stated","total_value":209589.94,"total_display":"209,589.94","shares_owned_after":19812.0,"shares_owned_after_display":"19,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":4430134,"accession":"0001593968-21-000076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-000076","line_url":"/filing/0001593968-21-000076#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1179.0,"shares_display":"1,179","price_per_share":19.68,"price_display":"19.68","price_state":"stated","total_value":23202.72,"total_display":"23,202.72","shares_owned_after":17556.0,"shares_owned_after_display":"17,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-06","scope":"insider"},{"id":4430128,"accession":"0001593968-21-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-21-000076","line_url":"/filing/0001593968-21-000076#line-1","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":821.0,"shares_display":"821","price_per_share":19.763,"price_display":"19.76","price_state":"stated","total_value":16225.423,"total_display":"16,225.42","shares_owned_after":18735.0,"shares_owned_after_display":"18,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-06","scope":"insider"},{"id":2157545,"accession":"0001593968-20-002209","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001593968-20-002209","line_url":"/filing/0001593968-20-002209#line-3","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9877.0,"shares_display":"9,877","price_per_share":17.01,"price_display":"17.01","price_state":"stated","total_value":168007.77,"total_display":"168,007.77","shares_owned_after":10256.0,"shares_owned_after_display":"10,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider"},{"id":2764273,"accession":"0001593968-20-002126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002126","line_url":"/filing/0001593968-20-002126#line-1","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1910.0,"shares_display":"1,910","price_per_share":28.06,"price_display":"28.06","price_state":"stated","total_value":53594.6,"total_display":"53,594.60","shares_owned_after":10256.0,"shares_owned_after_display":"10,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":2764225,"accession":"0001593968-20-001758","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001593968-20-001758","line_url":"/filing/0001593968-20-001758#line-3","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8375.0,"shares_display":"8,375","price_per_share":24.07,"price_display":"24.07","price_state":"stated","total_value":201586.25,"total_display":"201,586.25","shares_owned_after":10256.0,"shares_owned_after_display":"10,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":2764217,"accession":"0001593968-20-001758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001758","line_url":"/filing/0001593968-20-001758#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":23.13,"price_display":"23.13","price_state":"stated","total_value":34741.26,"total_display":"34,741.26","shares_owned_after":18631.0,"shares_owned_after_display":"18,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":2509581,"accession":"0001209191-20-030155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-030155","line_url":"/filing/0001209191-20-030155#line-2","is_derivative":false,"issuer_cik":"0001635616","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001635616","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9877.0,"shares_display":"9,877","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":148155.0,"total_display":"148,155.00","shares_owned_after":10256.0,"shares_owned_after_display":"10,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-18","scope":"insider"},{"id":4998187,"accession":"0001209191-17-066069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-066069","line_url":"/filing/0001209191-17-066069#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65223.0,"shares_display":"65,223","price_per_share":8.1135,"price_display":"8.11","price_state":"stated","total_value":529186.8105,"total_display":"529,186.81","shares_owned_after":72603.0,"shares_owned_after_display":"72,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-15","scope":"insider"},{"id":4786291,"accession":"0001209191-17-063682","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-063682","line_url":"/filing/0001209191-17-063682#line-3","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.3998,"price_display":"9.40","price_state":"stated","total_value":93998.0,"total_display":"93,998.00","shares_owned_after":73718.0,"shares_owned_after_display":"73,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-04","scope":"insider"},{"id":4542900,"accession":"0001209191-17-060714","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-060714","line_url":"/filing/0001209191-17-060714#line-4","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4062.0,"shares_display":"4,062","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":32496.0,"total_display":"32,496.00","shares_owned_after":73718.0,"shares_owned_after_display":"73,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-14","scope":"insider"},{"id":4542891,"accession":"0001209191-17-060714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-060714","line_url":"/filing/0001209191-17-060714#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":8.0132,"price_display":"8.01","price_state":"stated","total_value":14543.958,"total_display":"14,543.96","shares_owned_after":73718.0,"shares_owned_after_display":"73,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-10","filed_date":"2017-11-14","scope":"insider"},{"id":4226464,"accession":"0001209191-17-059858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-059858","line_url":"/filing/0001209191-17-059858#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4123.0,"shares_display":"4,123","price_per_share":8.0358,"price_display":"8.04","price_state":"stated","total_value":33131.6034,"total_display":"33,131.60","shares_owned_after":73718.0,"shares_owned_after_display":"73,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-06","filed_date":"2017-11-08","scope":"insider"},{"id":4992063,"accession":"0001209191-17-056051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-056051","line_url":"/filing/0001209191-17-056051#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.587,"price_display":"10.59","price_state":"stated","total_value":105870.0,"total_display":"105,870.00","shares_owned_after":73718.0,"shares_owned_after_display":"73,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4163778,"accession":"0001209191-17-052894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-052894","line_url":"/filing/0001209191-17-052894#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3557.0,"shares_display":"3,557","price_per_share":10.9858,"price_display":"10.99","price_state":"stated","total_value":39076.4906,"total_display":"39,076.49","shares_owned_after":73718.0,"shares_owned_after_display":"73,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-14","scope":"insider"},{"id":4325033,"accession":"0001209191-17-051619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-051619","line_url":"/filing/0001209191-17-051619#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.6948,"price_display":"11.69","price_state":"stated","total_value":116948.0,"total_display":"116,948.00","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-06","scope":"insider"},{"id":4359175,"accession":"0001209191-17-048357","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-048357","line_url":"/filing/0001209191-17-048357#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.1795,"price_display":"12.18","price_state":"stated","total_value":121795.0,"total_display":"121,795.00","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-07","filed_date":"2017-08-09","scope":"insider"},{"id":5352261,"accession":"0001209191-17-044233","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-044233","line_url":"/filing/0001209191-17-044233#line-4","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.0167,"price_display":"11.02","price_state":"stated","total_value":110167.0,"total_display":"110,167.00","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-06","scope":"insider"},{"id":4109592,"accession":"0001209191-17-037969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-037969","line_url":"/filing/0001209191-17-037969#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.0025,"price_display":"10.00","price_state":"stated","total_value":80020.0,"total_display":"80,020.00","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-05","scope":"insider"},{"id":4109309,"accession":"0001209191-17-033761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033761","line_url":"/filing/0001209191-17-033761#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1011.0,"shares_display":"1,011","price_per_share":9.65,"price_display":"9.65","price_state":"stated","total_value":9756.15,"total_display":"9,756.15","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-17","filed_date":"2017-05-18","scope":"insider"},{"id":5351280,"accession":"0001209191-17-032489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-032489","line_url":"/filing/0001209191-17-032489#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":9.7156,"price_display":"9.72","price_state":"stated","total_value":77724.8,"total_display":"77,724.80","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-15","scope":"insider"},{"id":4941530,"accession":"0001209191-17-025393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-025393","line_url":"/filing/0001209191-17-025393#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.7056,"price_display":"10.71","price_state":"stated","total_value":85644.8,"total_display":"85,644.80","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-04","scope":"insider"},{"id":4651684,"accession":"0001209191-17-019994","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-019994","line_url":"/filing/0001209191-17-019994#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":11.0001,"price_display":"11.00","price_state":"stated","total_value":88000.8,"total_display":"88,000.80","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-10","scope":"insider"},{"id":4102276,"accession":"0001209191-17-004638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-004638","line_url":"/filing/0001209191-17-004638#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (EVP of Research and Dev)","officer_title":"EVP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":11.8572,"price_display":"11.86","price_state":"stated","total_value":94857.6,"total_display":"94,857.60","shares_owned_after":49300.0,"shares_owned_after_display":"49,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-19","scope":"insider"},{"id":2737418,"accession":"0001209191-16-121444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-121444","line_url":"/filing/0001209191-16-121444#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":905.0,"shares_display":"905","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":7421.0,"total_display":"7,421.00","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"},{"id":2770225,"accession":"0001209191-16-090832","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-090832","line_url":"/filing/0001209191-16-090832#line-6","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18638.0,"shares_display":"18,638","price_per_share":21.57,"price_display":"21.57","price_state":"stated","total_value":402021.66,"total_display":"402,021.66","shares_owned_after":14406.0,"shares_owned_after_display":"14,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-11","scope":"insider"},{"id":2770219,"accession":"0001209191-16-090832","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-090832","line_url":"/filing/0001209191-16-090832#line-5","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1706.0,"shares_display":"1,706","price_per_share":22.4,"price_display":"22.40","price_state":"stated","total_value":38214.4,"total_display":"38,214.40","shares_owned_after":12700.0,"shares_owned_after_display":"12,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-11","scope":"insider"},{"id":2770212,"accession":"0001209191-16-090832","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-090832","line_url":"/filing/0001209191-16-090832#line-4","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":956.0,"shares_display":"956","price_per_share":23.51,"price_display":"23.51","price_state":"stated","total_value":22475.56,"total_display":"22,475.56","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-11","scope":"insider"},{"id":2770208,"accession":"0001209191-16-090832","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-090832","line_url":"/filing/0001209191-16-090832#line-3","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":23.29,"price_display":"23.29","price_state":"stated","total_value":16303.0,"total_display":"16,303.00","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-11","scope":"insider"},{"id":8752843,"accession":"0001209191-15-085128","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-085128","line_url":"/filing/0001209191-15-085128#line-5","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13289.0,"shares_display":"13,289","price_per_share":29.98,"price_display":"29.98","price_state":"stated","total_value":398404.22,"total_display":"398,404.22","shares_owned_after":5976.0,"shares_owned_after_display":"5,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider"},{"id":8752842,"accession":"0001209191-15-085128","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-085128","line_url":"/filing/0001209191-15-085128#line-4","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5735.0,"shares_display":"5,735","price_per_share":29.43,"price_display":"29.43","price_state":"stated","total_value":168781.05,"total_display":"168,781.05","shares_owned_after":19265.0,"shares_owned_after_display":"19,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider"},{"id":8752839,"accession":"0001209191-15-085128","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-085128","line_url":"/filing/0001209191-15-085128#line-3","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3376.0,"shares_display":"3,376","price_per_share":30.03,"price_display":"30.03","price_state":"stated","total_value":101381.28,"total_display":"101,381.28","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider"},{"id":8752836,"accession":"0001209191-15-085128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-085128","line_url":"/filing/0001209191-15-085128#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":29.56,"price_display":"29.56","price_state":"stated","total_value":76856.0,"total_display":"76,856.00","shares_owned_after":3376.0,"shares_owned_after_display":"3,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider"},{"id":8697356,"accession":"0001209191-15-081145","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-15-081145","line_url":"/filing/0001209191-15-081145#line-9","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001635616","owner_name":"Brockstedt Dirk G.","owner_url":"/insider/0001635616","role":"Officer (Sr. VP of Research and Dev)","officer_title":"Sr. VP of Research and Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16947.0,"shares_display":"16,947","price_per_share":28.76,"price_display":"28.76","price_state":"stated","total_value":487395.72,"total_display":"487,395.72","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-17","filed_date":"2015-11-18","scope":"insider"}],"next_cursor":"2015-11-17|8697356","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Officer (CHIEF SCIENTIFIC OFFICER)","n_filings":22,"first_seen":"2020-05-18","last_seen":"2024-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"ADURO BIOTECH, INC.","url":"/issuer/0001435049","role":"Officer (EVP of Research and Dev)","n_filings":19,"first_seen":"2015-11-18","last_seen":"2017-12-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001635616","retrieved_at":"2026-08-20T21:09:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}